Clinical observation of Compound Xuanju Capsule combined with Testosterone Undecanoate Capsule in treatment of oligoasthenospermia
Gang LIU,Chun LIU,Zhi-gang CUI,Xiao-yong LIU,Rui CHEN,Lu CHAO,Xiao-tong SONG,Zhi-rong LING,Ming YUE,Yu XIANG,Xiao-feng WANG
DOI: https://doi.org/10.7501/j.issn.1674-5515.2014.09.010
2014-01-01
Abstract:Objective To investigate the clinical efficacy of Compound Xuanju Capsule combined with Testosterone Undecanoate Capsule in the treatment of oligoasthenospermia.Methods Patients with oligoasthenospermia (120 cases) in the 306thHospital of PLA from December 2012 to November 2013 were randomly divided into Compound Xuanju Capsule (40 cases), Testosterone Undecanoate Capsule (32 cases), and combined treatment (48 cases) groups. Patients in the Compound Xuanju Capsule group werepo administered with Compound Xuanju Capsule, 3 grains/time, three times daily. Patients in the Testosterone Undecanoate Capsule group werepo administered with Testosterone Undecanoate Capsule, 1 grain/time, twice daily. Patients in the combined treatment group were given Compound Xuanju Capsule and Testosterone Undecanoate Capsule, and the usage and dosage were the same with the above two groups. One month was as a period of treatment, and three groups were administered for three courses. The treatment efficacy was evaluated, while the related parameters of semen were analyzed.Results The efficacies on the patients in the Compound Xuanju Capsule, Testosterone Undecanoate Capsule, and combined treatment groups were 75.0%, 68.8%, and 91.7%, and the clinical efficacies in combined treatment group were higher than those in the other two groups with significant difference (P < 0.05). After treatment, semen volume, sperm survival rate, a grade sperm ratio, (a + b) sperm, sperm density, sperm activity rate, linear motion forward speed, the serum level of T,α-glucoside, sperm acrosome enzyme, fructose and seminal plasma zinc in three groups were improved obviously, and the differences were statistically significant before and after treatment in the same group (P < 0.05). The results in the combined treatment group was higher than other two groups, and the difference was statistically significant (P < 0.05). After treatment, liquefaction time, sperm deformity rate of sperm, serum FSH, LH, DNA fragmentation index, seminal plasma elastase were reduced in three groups, and the differences were statistically significant before and after treatment in the same group (P < 0.05). Combined treatment group was lower than other two groups, and the difference was statistically significant (P < 0.05). ConclusionCompound Xuanju Capsule combined with Testosterone Undecanoate Capsule has a good clinical efficacy in the treatment of oligoasthenospermia, and can improve sperm related indicators, which is better than that of two drug used alone.